Popik P - Search Results

1

Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor.

Sałat K, Siwek A, Starowicz G, Librowski T, Nowak G, Drabik U, Gajdosz R, Popik P. Sałat K, et al. Among authors: popik p. Neuropharmacology. 2015 Dec;99:301-7. doi: 10.1016/j.neuropharm.2015.07.037. Epub 2015 Aug 1. Neuropharmacology. 2015. PMID: 26240948

2

Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.

Paul IA, Nowak G, Layer RT, Popik P, Skolnick P. Paul IA, et al. Among authors: popik p. J Pharmacol Exp Ther. 1994 Apr;269(1):95-102. J Pharmacol Exp Ther. 1994. PMID: 8169857

3

Ca2+ antagonists effect an antidepressant-like adaptation of the NMDA receptor complex.

Nowak G, Paul IA, Popik P, Young A, Skolnick P. Nowak G, et al. Among authors: popik p. Eur J Pharmacol. 1993 Sep 15;247(1):101-2. doi: 10.1016/0922-4106(93)90144-x. Eur J Pharmacol. 1993. PMID: 8258355

4

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.

Popik P, Skolnick P. Popik P, et al. Pharmacol Biochem Behav. 1996 Apr;53(4):791-7. doi: 10.1016/0091-3057(95)02163-9. Pharmacol Biochem Behav. 1996. PMID: 8801580

5

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.

Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R. Skolnick P, et al. Among authors: popik p. Pharmacopsychiatry. 1996 Jan;29(1):23-6. doi: 10.1055/s-2007-979537. Pharmacopsychiatry. 1996. PMID: 8852530 Review.

6

Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors.

Nowak G, Legutko B, Skolnick P, Popik P. Nowak G, et al. Among authors: popik p. Eur J Pharmacol. 1998 Jan 26;342(2-3):367-70. doi: 10.1016/s0014-2999(97)01589-6. Eur J Pharmacol. 1998. PMID: 9548410

7

Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists.

Popik P, Mamczarz J, Fraczek M, Widła M, Hesselink M, Danysz W. Popik P, et al. Neuropharmacology. 1998 Aug;37(8):1033-42. doi: 10.1016/s0028-3908(98)00105-1. Neuropharmacology. 1998. PMID: 9833632

8

Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test.

Popik P, Kozela E. Popik P, et al. Pol J Pharmacol. 1999 May-Jun;51(3):223-31. Pol J Pharmacol. 1999. PMID: 10600036

9

Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models.

Kłodzińska A, Chojnacka-Wójcik E, Pałucha A, Brański P, Popik P, Pilc A. Kłodzińska A, et al. Among authors: popik p. Neuropharmacology. 1999 Dec;38(12):1831-9. doi: 10.1016/s0028-3908(99)00066-0. Neuropharmacology. 1999. PMID: 10608278

10

Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.

Popik P, Kozela E, Danysz W. Popik P, et al. Naunyn Schmiedebergs Arch Pharmacol. 2000 Apr;361(4):425-32. doi: 10.1007/s002109900205. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 10763858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters